(Q35944690)

11 August 2017

BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas (English)

1 reference

11 August 2017

0 references

1 reference

8

Laurence de Leval

0 references

Andrew Wotherspoon

9

object named as

Andrew Wotherspoon

1 reference

11 August 2017

Qingguo Yan

1

1 reference

11 August 2017

Yuanxue Huang

2

1 reference

11 August 2017

A James Watkins

3

1 reference

11 August 2017

Sylvia Kocialkowski

4

1 reference

11 August 2017

Naiyan Zeng

5

1 reference

11 August 2017

Rifat A Hamoudi

6

1 reference

11 August 2017

Peter G Isaacson

7

1 reference

11 August 2017

Ming-Qing Du

10

1 reference

11 August 2017

18 November 2011

1 reference

11 August 2017

1 reference

11 August 2017

97

1 reference

11 August 2017

4

1 reference

11 August 2017

595-598

1 reference

A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

Oncogenically active MYD88 mutations in human lymphoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

Frequent inactivation of A20 in B-cell lymphomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

A20: central gatekeeper in inflammation and immunity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

Deubiquitylation and regulation of the immune response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

TCR-induced NF-kappaB activation: a crucial role for Carma1, Bcl10 and MALT1.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347666

A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22102703

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22102703

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3324/HAEMATOL.2011.054080

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22102703

1 reference